Pang Xie Jia

Pang Xie Jia (Phlomis younghusbandii Herb) is the dried root of Phlomis younghusbandii Mukerjee, a perennial herbaceous plant in the family Lamiaceae. In the traditional Tibetan and TCM classification systems, Pang Xie Jia is considered pungent and bitter in flavor with a warm nature. It enters the Liver, Spleen, and Gallbladder meridians, giving it a traditional role in formulas that address Wind-Damp Bi syndrome, pain, Qi stagnation, and cough.

Botanical description: Phlomis younghusbandii is a perennial herb growing 20–50 cm tall. The plant has a thick, fusiform taproot that can reach up to 2.5 cm in diameter, with branched lateral roots. The stems are erect, often purple-brown, and covered with stellate hairs. The leaves are ovate-triangular to lanceolate, 2–6 cm long, with crenate margins and a wrinkled surface due to impressed veins. The leaves are greenish-brown when dried. The inflorescence is a verticillaster (whorled cluster) with purple or pink flowers, typical of the Lamiaceae family. The plant produces small nutlets as fruits. The medicinal organ is the dried root, which is brownish externally and yellowish-white internally, with a characteristic aromatic odor.

Habitat and distribution: Phlomis younghusbandii is native to the Tibetan Plateau and surrounding regions, primarily distributed in Tibet Autonomous Region and adjacent areas of southwestern China (including Sichuan and Yunnan provinces). It typically grows on grassy slopes, along stream banks, and in forest margins at elevations of 2,800–4,300 meters. The plant is well adapted to the high-altitude, cold, and arid conditions of the Tibetan Plateau. The roots are traditionally harvested in autumn, cleaned, and dried in the sun for medicinal use.

Tibetan medical context: In Tibetan medicine, Pang Xie Jia is known as "Bangjia" (or "Lumuer" in certain dialects). It is classified as a medicinal herb for treating disorders involving Wind (rlung) and Dampness (bad kan). The herb is listed in the Chinese Pharmacopoeia (Tibetan medicine section) and is an officially recognized medicinal material in the Tibetan medicinal system. Its traditional use dates back centuries in Tibetan ethnomedical practice, where it is employed for rheumatic conditions, cough, colds, and pain.

In the traditional Chinese medicine theoretical framework, Pang Xie Jia is understood in terms of its effects on specific patterns of disharmony (zheng). Because Pang Xie Jia enters the Liver, Spleen, and Gallbladder meridians and has a pungent, bitter, and warm quality, it is traditionally indicated for a range of patterns involving Wind-Damp, Qi stagnation, and cough.

Dispelling Wind-Damp and stopping pain: Pang Xie Jia is considered a useful herb in TCM for dispelling Wind-Dampness and alleviating pain. In TCM theory, when Wind and Dampness invade the channels and collaterals, they may cause Bi syndrome (painful obstruction), characterized by joint pain, stiffness, and limited mobility. Pang Xie Jia is traditionally used to address these presentations, particularly when the condition involves the lower body or is associated with cold and damp environmental factors. It is commonly combined with other Wind-Damp dispelling herbs such as Fang Feng and Qiang Huo in clinical practice.

Regulating Qi and treating cough: Pang Xie Jia is also traditionally used to regulate Qi and treat cough. In TCM theory, its pungent and warm properties are believed to help disperse stagnant Qi and restore the normal descending function of the Lung. It may be used for coughs that are accompanied by a sensation of chest fullness or Qi stagnation. When used for this purpose, it is often combined with Qi-regulating herbs such as Chen Pi.

Tibetan medical indications: Within the Tibetan medical tradition, Pang Xie Jia (Bangjia) is primarily used for rheumatic disorders (similar to Bi syndrome in TCM), rheumatoid arthritis, cough, colds, and various pain conditions. It is considered to have warming, drying, and pain-relieving properties. In Tibetan medical theory, it is believed to pacify Wind (rlung) and Dampness (bad kan) imbalances, which are considered the root causes of many chronic rheumatic and digestive disorders.

Classical literature references: Pang Xie Jia is recorded in the Chinese Pharmacopoeia as a Tibetan medicinal material. Its traditional uses are documented in Tibetan medical classics, including the Four Tantras (rGyud bZhi), the foundational text of Tibetan medicine. The herb has also been included in modern Chinese pharmacopoeial standards for Tibetan medicinal materials, which specify quality markers and identification criteria for the dried root.

Pang Xie Jia contains a range of bioactive compounds that have been the subject of preliminary pharmacological investigation. The following overview summarizes the major chemical constituents identified in the root of Phlomis younghusbandii and what is currently known about them from published research.

Iridoid glycosides: Iridoid glycosides are one of the principal classes of compounds identified in Pang Xie Jia. Sesamoside is a major iridoid glycoside that has been studied for its potential anti-hypoxic and anti-oxidant activities. A network pharmacology study (PMID: 39253070) investigated the anti-hypoxic mechanism of sesamoside, suggesting it may act through multiple molecular targets involved in hypoxia response pathways. Phlomiol is another iridoid glycoside isolated from the plant that has been studied for anti-tumor activity in pre-clinical models (PMID: 20707081). However, most evidence comes from in-vitro and computational studies; robust human clinical data are lacking.

Phenylethanoid glycosides: Phenylethanoid glycosides, including phlomisoside F, are another important class of compounds from Pang Xie Jia. A study by Luan et al. (PMID: 30784766) reported that phenylethanoid glycosides from Phlomis younghusbandii ameliorated acute hypobaric hypoxia-induced brain impairment in rats, suggesting potential neuroprotective effects. Phlomisoside F has been specifically studied for its anti-inflammatory activity (PMID: 26263166) and its effect on complete Freund's adjuvant-induced arthritis in animal models (PMID: 28352356). These phenylethanoid glycosides are believed to contribute to the herb's traditional anti-inflammatory and analgesic properties.

Flavonoids and saponins: Flavonoids and saponins have also been identified in Pang Xie Jia. These compounds are widely distributed in the Lamiaceae family and are known to contribute to anti-oxidant, anti-inflammatory, and immunomodulatory activities. HPLC methods have been developed for the simultaneous determination of multiple iridoid glycosides and phenylethanoid glycosides in the herb (PMID: 21657079), providing a basis for quality control of commercial Pang Xie Jia preparations.

Other constituents: Imperatorin, a furanocoumarin, has been isolated from the root of Phlomis younghusbandii. A study by Zhang et al. (PMID: 28990061) demonstrated that imperatorin possesses notable anti-inflammatory activity in vitro and in vivo through inhibition of the NF-kappaB pathway. The plant also contains various other secondary metabolites that are still being characterized.

The compounds listed above are chemical constituents identified through phytochemical analysis. Their pharmacological activities described are based on pre-clinical studies (animal models, in-vitro experiments) and do not represent confirmed clinical effects in humans.

Pang Xie Jia is primarily used in Tibetan medicine and TCM as a single herb or as part of Tibetan medicinal formulas. Unlike many well-known TCM herbs, it does not have a widely documented history in classical Chinese formulas from the Han or Ming dynasties. Instead, its use is rooted in the Tibetan ethnomedical tradition.

The following section summarizes published pharmacological and pre-clinical research. Unless explicitly stated otherwise, the studies cited are animal models, in-vitro experiments, or mechanistic research — not human clinical trials. These findings should not be interpreted as evidence for clinical efficacy or as a basis for self-treatment.

Anti-inflammatory effects of phlomisoside F: Phlomisoside F, a phenylethanoid glycoside isolated from Pang Xie Jia, has been the most extensively studied compound from this herb. A study by Li et al. (PMID: 26263166) investigated the anti-inflammatory activity of phlomisoside F in carrageenan-induced rat paw edema and other inflammatory models. The results suggested that phlomisoside F exhibited significant anti-inflammatory effects, potentially through inhibition of pro-inflammatory cytokine production and modulation of the NF-kappaB signaling pathway. A subsequent study by Zhang et al. (PMID: 28352356) demonstrated that phlomisoside F reduced the severity of complete Freund's adjuvant-induced arthritis in rats, suggesting potential anti-arthritic properties. These findings are consistent with the traditional use of Pang Xie Jia for rheumatic conditions, though human clinical trials are needed to confirm these effects.

Anti-hypoxic and neuroprotective potential: A study by Luan et al. (PMID: 30784766) investigated the effects of phenylethanoid glycosides from Phlomis younghusbandii on acute hypobaric hypoxia-induced brain impairment in rats. The results suggested that these compounds could ameliorate hypoxia-induced brain injury, potentially through anti-oxidant and anti-inflammatory mechanisms. A network pharmacology study by Song et al. (PMID: 39253070) further explored the anti-hypoxic mechanism of sesamoside, one of the major iridoid glycosides in the plant, identifying multiple molecular targets and pathways potentially involved in the hypoxic response. These pre-clinical studies provide mechanistic insights but do not establish clinical efficacy for human conditions.

Anti-inflammatory activity of imperatorin: Imperatorin, a furanocoumarin isolated from the root of Phlomis younghusbandii, was studied by Zhang et al. (PMID: 28990061) for its anti-inflammatory properties. The study demonstrated that imperatorin inhibited inflammation in both in-vitro and in-vivo models through suppression of the NF-kappaB signaling pathway. While these findings are scientifically interesting, their clinical significance for human inflammatory conditions has not been established.

Anti-inflammatory and anti-nociceptive activities of the whole extract: Wang et al. (PMID: 24598860) investigated the anti-inflammatory and anti-nociceptive (pain-relieving) activities of the methanol extract from the aerial part of Phlomis younghusbandii. The study reported that the extract exhibited significant anti-inflammatory effects in animal models of acute inflammation and demonstrated pain-relieving properties in nociceptive tests. These findings provide some pre-clinical support for the traditional use of the herb for pain and inflammation.

What the research does NOT show: Despite these pre-clinical findings, the research on Pang Xie Jia and its active compounds does NOT demonstrate conclusive clinical efficacy for any specific disease in humans. There is no robust evidence from large-scale, randomized, placebo-controlled clinical trials that Pang Xie Jia can treat, cure, or prevent rheumatoid arthritis, inflammatory disorders, hypoxic conditions, or any other medical condition. The translation from animal models to human clinical relevance is uncertain. This page does not endorse Pang Xie Jia as a treatment for any condition.

Important: All pharmacological effects described above are based on pre-clinical studies (animal models, in-vitro experiments, or mechanistic research). They do not constitute evidence of clinical efficacy in humans. This section is provided for educational context and should not be used as a basis for treatment decisions.

General safety profile: The safety profile of Pang Xie Jia is not well established due to the very limited availability of clinical data. Traditional use in Tibetan medicine suggests it is generally well tolerated when used appropriately under professional guidance, but no systematic toxicological studies or human clinical trials have been published to confirm its safety profile. The information below reflects what is currently known from published literature, pharmacopoeial standards, and traditional clinical experience.

Yin deficiency with Heat: In traditional TCM theory, Pang Xie Jia is warm, pungent, and bitter in nature. Individuals with Yin deficiency patterns complicated by Heat — characterized by night sweats, five-palm heat, dry mouth and throat, red tongue with scanty coating, and a thin, rapid pulse — should generally avoid Pang Xie Jia. Its warm nature may theoretically aggravate deficiency Heat and further deplete Yin fluids.

Damp-Heat conditions: While Pang Xie Jia is traditionally used for Wind-Damp patterns, its warm nature may be inappropriate for Damp-Heat conditions, where Heat and Dampness are combined. In such cases, using a warm herb may theoretically worsen the Heat component of the pattern. Damp-Heat patterns typically present with yellow, greasy tongue coating, a feeling of heaviness, and signs of inflammation.

Pregnancy and lactation: There are no published safety data on the use of Pang Xie Jia during pregnancy or lactation. Due to the absence of safety information and the presence of bioactive compounds (iridoid glycosides, phenylethanoid glycosides) whose effects on fetal development are unknown, the use of Pang Xie Jia during pregnancy and lactation is not recommended. Do not use Pang Xie Jia during pregnancy or while breastfeeding without direct supervision from a qualified healthcare professional.

Drug interactions: There are no published clinical studies on drug interactions involving Pang Xie Jia. Pre-clinical data suggest that certain constituents, including iridoid glycosides and phenylethanoid glycosides, may have anti-inflammatory and immunomodulatory activities, which could theoretically interact with immunosuppressive or anti-inflammatory medications. However, clinical interaction data are entirely absent. Given the very limited evidence base, it is prudent to avoid combining Pang Xie Jia with any prescription medications without professional supervision.

Reported side effects: Based on available traditional use reports, side effects associated with Pang Xie Jia are not well documented. In the absence of systematic safety monitoring, the full side effect profile of this herb is unknown. Any suspected adverse effects should be reported to a healthcare professional.

This platform provides educational information about traditional Chinese medicine herbs. It does not recommend, endorse, or prescribe the use of Pang Xie Jia or any other herbal product for the treatment of any medical condition. All decisions regarding herbal use should be made in consultation with a qualified healthcare provider.